
Q&A: Skin Cancer Prevention Beyond Summer, With Jill Cowan, APRN, FNP-BC
Key Takeaways
- Cumulative daily UV exposure persists in winter via cloud penetration, snow albedo, and altitude effects, necessitating consistent SPF use beyond summer months.
- Full-body skin examinations for new patients presenting with a concerning spot can improve early detection, particularly for difficult-to-self-visualize sites like scalp, ears, and back.
For Healthy Skin Month, a dermatology nurse practitioner shares why sunscreen matters in winter and how clinicians can close gaps in skin cancer screening.
For Healthy Skin Month in November, Jill Cowan, APRN, FNP-BC, spoke with the editorial team about one of the most persistent gaps in dermatology: patients who put sunscreen away once summer ends. In this Q&A, Cowan explains why colder, cloudier months carry more UV risk than many patients assume. She also describes a missed opportunity for early detection she sees in routine visits, and simple adjustments dermatology and primary care clinicians can make to catch
Cowan also shares practical counseling strategies she uses to turn patients’ knowledge about sunscreen into daily habit. She identifies the patient populations she believes are most overlooked in screening and prevention, at a time when patients with skin of color are more likely to be diagnosed with melanoma at advanced stages.¹ To close, she discusses the development she is watching most closely heading into the new year: bemotrizinol, the first new sunscreen filter added by the US Food and Drug Administration (FDA) in decades, and what sets it apart from filters already on the market.²
Dermatology Times: Healthy Skin Month lands in November, when sun protection tends to fall off patients’ radar. What message do you most want dermatology providersto reinforce with patients during the colder months, and why does year-round photoprotection still matter?
Jill Cowan, APRN, FNP-BC: UV exposure does not stop in the summer. It is the daily, cumulative UV exposure that increases the risk for skin cancer. Therefore, daily use of SPF is critical. Even on gloomy winter days, there remains UV exposure that penetrates through clouds. That means that even though you may not feel the direct effects of it, your skin is still susceptible to its potentially harmful effects. Furthermore, in winter months it is important to remember that snow can reflect UV and UV exposure increases with increased elevation.
Dermatology Times: What are the most common missed opportunities you see for catching skin cancer early, and what can dermatology providersand primary care clinicians do differently during routine visits to close those gaps?
Jill Cowan, APRN, FNP-BC: For patients that may be new to your office who are coming in for a spot of concern, I strongly recommend offering a full body skin examination. This is especially important if they have not had a skin check in years or for some individuals who’ve never had one. We are able to exam locations that are hard for patients to see on themselves such as the scalp, ears, and back.
Dermatology Times: Many patients know they should wear sunscreen and do self-exams but don’t follow through. What counseling strategies have you found actually change behavior?
Jill Cowan, APRN, FNP-BC: One of my favorite strategies is to ask patient what their barriers are to wearing daily SPF. A common answer that I often get is that it has been hard to make it a habit. For that, I recommend patients to keep SPF bottles in a few, commonly visited locations. That may be their bathroom vanity, bedside table, coffee table where they keep their car keys, purse, or work desk. That way, it is convenient and accessible. Some patients may also say that they have not found an SPF texture they like. I will then ask patients if they would prefer a product that is lightweight or one that is more moisturizing. Based on their preferences, I provide patients with samples of various SPFs that they can try out. Many of these samples are able to be purchased at their local grocery store, which may make it easier for patients as well.
Dermatology Times: Which patient groups do you feel are most overlooked when it comes to skin cancer screening and prevention, including patients with skin of color who are often diagnosed at later stages, and how should clinicians tailor their approach?
Jill Cowan, APRN, FNP-BC: The patient group that I feel is most overlooked when it comes to skin cancer screening and prevention are those with deeper skin tones. This is because there is misinformation that these patients are not at risk for skin cancer, which is incorrect. All patients, regardless of skin type, are at risk for melanoma, SCC, and BCC. In addition, patients that have received a solid organ transplant and are on immunosuppressants are also at increased risk for skin cancer. It is important to educate patients at every skin check appointment about what to monitor for during their self-skin exams.
Dermatology Times: From new sunscreen filters and AI-assisted lesion detection to evolving screening recommendations, what developments are you most watching in skin cancer prevention, and what should clinicians be prepared to discuss with patients in the coming year?
Jill Cowan, APRN, FNP-BC: The development that I am most watching in skin cancer prevention is the new UV filter that was recently approved by the FDA, bemotrizinol (BEMT). This is the first SPF filter that has been approved in the US since the 1990s. What makes this new organic chemical UV filter different from current market is the broad spectrum UVA and UVB coverage that it has. It also is photostable and increases the stability of avobenzone. This chemical filter is also larger in molecular size which decreases systemic absorption.
References
- American Academy of Dermatology. Largest study on racial differences in men with melanoma shows men with skin of color have lowest survival rates. Published July 11, 2023. Accessed November 18, 2026.
https://www.aad.org/news/melanoma-study-men-skin-of-color-lowest-survival-rates - HCPLive. FDA adds bemotrizinol as first new sunscreen ingredient in decades.
https://www.hcplive.com/view/fda-adds-bemotrizinol-first-new-sunscreen-ingredient-decades . Published June 9, 2026. Accessed November 18, 2026
Related to this article








